Semaglutide, a glucagon like peptide-1 receptor agonist with cardiovascular benefits for management of type 2 diabetes
Extent and health consequences of chronic sleep loss and sleep disorders
In contrast, BRP appears to act specifically in the hypothalamus, which controls appetite and metabolism. Svensson is the senior author of the study, published March 5, 2025, in Nature
Automated Alerts: Patients can sign-up to receive automated email alerts, delivered when a GLP-1 drug is reported in supply in their area or when the status of a GLP-1 drug changes on the FDA's Drug Shortage List
showed similar results, namely, that Pro198Leu-associated GPx1 activities were decreased in breast cancer but were associated with increased breast cancer risk among Danish females [89]
A diagnosis of "obesity" is usually made with a BMI of greater than 30, while an "overweight" diagnosis is made with a BMI of greater than 27